PM Pharma ApS: Financial statements 2025
CVR: 42988197
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PM Pharma ApS (CVR 42988197) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,220,588 and a net result of DKK -19,580 compared with DKK 6,341 the year before. That is a decrease of 3% compared with the year before. Equity in the 2025 report amounted to DKK 151,479. The solvency ratio was 21.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,220,588
- Profit/Loss
- DKK -19,580
- Equity
- DKK 151,479
- Total Assets
- DKK 719,135
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.2 mio. | -20 t. | 151 t. | 2 |
| 2024 | - | 3.3 mio. | 6 t. | 171 t. | 3 |
| 2023 | - | 2.5 mio. | 27 t. | 165 t. | 3 |
| 2022 | - | 1 mio. | 188 t. | 228 t. | 2 |
Official annual report
How creditworthy is PM Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PM Pharma ApS has published its annual report for 2024. Gross profit came to DKK 3,320,571, and the net result was DKK 6,341.
About PM Pharma ApS
PM Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Installation af industrimaskiner og -udstyr. The management consists of Patrick Munck. The company is owned by PM Engineering ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,220,588 and a net result of DKK -19,580 compared with DKK 6,341 the year before. Equity in the 2025 report amounted to DKK 151,479.